Cell fate determination factor DACH1 represses cancer stemness in hepatocellular carcinoma via inhibiting Wnt/β-catenin signaling

被引：0
|
作者：
Zhu, Hongbin [1 ]
Wang, Dongxu [1 ]
Hu, Ling [2 ]
Wang, Qili [1 ]
Bai, Jun [1 ]
机构：
[1] PLA 983 Hosp, Dept Gastroenterol & Hepatol, Tianjin, Peoples R China
[2] PLA 983 Hosp, Dept Oncol, Tianjin, Peoples R China
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
DACH1; Wnt/beta-catenin signaling; Hepatocellular carcinoma; Stemness;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP 0288
引用
收藏
页码：217 / 218
页数：2
相关论文
共 50 条
  • [1] DACH1 is a novel predictive and prognostic biomarker in hepatocellular carcinoma as a negative regulator of Wnt/β-catenin signaling
    Liu, Yu
    Zhou, Rong
    Yuan, Xun
    Han, Na
    Zhou, Si
    Xu, Hanxiao
    Guo, Mingzhou
    Yu, Shiying
    Zhang, Cuntai
    Yin, Tiejun
    Wu, Kongming
    ONCOTARGET, 2015, 6 (11) : 8621 - 8634
  • [2] The cell fate determination factor DACH1 is expressed in estrogen receptor \#945; positive breast cancer and represses ER\#945; signaling
    Popov, Vladimir
    Zhou, Jie
    Shirley, L. Andrew
    Wu, Kongming
    Vadlamudi, Ratna K.
    Kumar, Rakesh
    Jiang, Jie
    Quong, Judy
    Rui, Hallgeir
    Yeow, Wen-Shuz
    Wang, Chenguang
    Pestell, Richard G.
    CANCER RESEARCH, 2009, 69
  • [3] The Cell Fate Determination Factor DACH1 Is Expressed in Estrogen Receptor-α-Positive Breast Cancer and Represses Estrogen Receptor-α Signaling
    Popov, Vladimir M.
    Zhou, Jie
    Shirley, L. Andrew
    Quong, Judy
    Yeow, Wen-Shuz
    Wright, Jennifer A.
    Wu, Kongming
    Rui, Hallgeir
    Vadlamudi, Ratna K.
    Jiang, Jie
    Kumar, Rakesh
    Wang, Chenguang
    Pestell, Richard G.
    CANCER RESEARCH, 2009, 69 (14) : 5752 - 5760
  • [4] Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling
    Zhang, Zhirong
    Yang, Jiayao
    Liu, Rui
    Ma, Jing
    Wang, Kai
    Wang, Xiaojun
    Tang, Ni
    GENES & DISEASES, 2024, 11 (05)
  • [5] Cell Fate Factor DACH1 Represses YB-1-Mediated Oncogenic Transcription and Translation
    Wu, Kongming
    Chen, Ke
    Wang, Chenguang
    Jiao, Xuanmao
    Wang, Liping
    Zhou, Jie
    Wang, Jing
    Li, Zhiping
    Addya, Sankar
    Sorensen, Poul H.
    Lisanti, Michael P.
    Quong, Andrew
    Ertel, Adam
    Pestell, Richard G.
    CANCER RESEARCH, 2014, 74 (03) : 829 - 839
  • [6] The cell fate factor DACH1 represses YB-I-mediated oncogenic transcription and translation
    Pestell, R. G.
    Wu, K.
    Chen, K.
    Wang, C.
    Jiao, X.
    Wang, J.
    Cal, S.
    Addya, S.
    Sorensen, P. H.
    Lisanti, M. P.
    Quong, A.
    Ertel, A.
    CANCER RESEARCH, 2013, 73
  • [7] Attenuation of Forkhead signaling by the retinal determination factor DACH1
    Zhou, Jie
    Wang, Chenguang
    Wang, Zhibin
    Dampier, Will
    Wu, Kongming
    Casimiro, Mathew C.
    Chepelev, Iouri
    Popov, Vladimir M.
    Quong, Andrew
    Tozeren, Aydin
    Zhao, Keji
    Lisanti, Michael P.
    Pestell, Richard G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) : 6864 - 6869
  • [8] DACH1 is a cell-fate determination factor that governs Forkhead protein function in tumorigenesis
    Zhou, Jie
    Zhang, Wei
    Dampier, Will
    Wang, Min
    Yu, Zuoren
    Wu, Kongming
    Popov, Vladimir
    Willmarth, Nicole
    Casimiro, Mathew
    Lisanti, Michael
    Tozeren, Aydin
    Pestell, Richard
    Wang, Chenguang
    CANCER RESEARCH, 2009, 69
  • [9] DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway
    Wang, Jing
    Zou, Yan
    Wu, Xuechao
    Chen, Mu
    Zhang, Shuai
    Lu, Xiaojie
    Wang, Qing
    ONCOTARGETS AND THERAPY, 2018, 11 : 5853 - 5863
  • [10] MicroRNA-552 promotes tumor cell proliferation and migration by directly targeting DACH1 via the Wnt/β-catenin signaling pathway in colorectal cancer
    Cao, Jia
    Yan, Xiu-Rui
    Liu, Ting
    Han, Xue-Bo
    Yu, Jing-Jing
    Liu, Shi-Hai
    Wang, Li-Bin
    ONCOLOGY LETTERS, 2017, 14 (03) : 3795 - 3802
12345